Calquence Market Outlook Strengthened by Precision Oncology Adoption

hat ein neuen Blog hinzugefügt Andere

2026-01-22 04:06:09 -

The Calquence Market is set for long-term growth as precision oncology becomes the standard of care in cancer treatment. Calquence (acalabrutinib) offers targeted inhibition with improved tolerability, making it a preferred therapy option in hematologic cancers. Market data reveals that the Calquence market reached USD 2.5 Billion in 2023 and is projected to grow to USD 20.6 Billion by 2030,...

0 Kommentare 0 Geteilt 404 Ansichten 0 Bewertungen